
Sign up to save your podcasts
Or


The OncoAlert🚨ROUND UP Now Out‼️
Covering May 15-22, 2025
REGISTER at http://OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/...
⭐️Discussing
✅Systemic tx for HR+/HER2- early stage and metastatic #BreastCancer
✅Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized #ProstateCancer
✅Characterization of Patients with Lymph Node Only Metastatic #UrothelialCarcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin vs Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial
✅NO LIMIT Study: in Advanced Gastric or Esophagogastric Junction Cancer
✅PRODIGE 29-UCGI 26 (NEOPAN)on #PancreaticCarcinoma
and more.....
By OncoAlert5
33 ratings
The OncoAlert🚨ROUND UP Now Out‼️
Covering May 15-22, 2025
REGISTER at http://OncoAlert360.com OR https://oncoalert.m-pages.com/nhMpwe/...
⭐️Discussing
✅Systemic tx for HR+/HER2- early stage and metastatic #BreastCancer
✅Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized #ProstateCancer
✅Characterization of Patients with Lymph Node Only Metastatic #UrothelialCarcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin vs Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial
✅NO LIMIT Study: in Advanced Gastric or Esophagogastric Junction Cancer
✅PRODIGE 29-UCGI 26 (NEOPAN)on #PancreaticCarcinoma
and more.....

67 Listeners

59 Listeners

190 Listeners

41 Listeners